ALLEN LEE F MD PhD 4
4 · Dova Pharmaceuticals Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
ALLEN LEE F MD PhD
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-07-01$14.19/sh−1,957$27,770→ 10,613 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.98 to $14.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.